You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: February 2, 2026

CALCIUM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Calcium patents expire, and when can generic versions of Calcium launch?

Calcium is a drug marketed by Amneal Pharms, Chartwell Rx, Heritage Pharms Inc, Hikma, Invagen Pharms, Lotus Pharm Co Ltd, Lupin Ltd, Mpp Pharma, Square Pharms, Suven Pharms, Chartwell Molecular, Padagis Us, Am Regent, Amneal, Extrovis, Intl Medication Sys, Medefil Inc, Somerset, Square Pharms Plc, Hospira, Bausch, Abbott, Abraxis Pharm, Lilly, B Braun Medical, Fresenius Kabi Usa, Nivagen Pharms Inc, and Hq Spclt Pharma. and is included in thirty-four NDAs. There are two patents protecting this drug.

The generic ingredient in CALCIUM is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Calcium

A generic version of CALCIUM was approved as calcium gluconate by FRESENIUS KABI USA on June 15^th, 2017.

Get Started Free

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CALCIUM?
What are the global sales for CALCIUM?
What is Average Wholesale Price for CALCIUM?

Summary for CALCIUM

US Patents:	0
Applicants:	28
NDAs:	34
Drug Prices:	Drug price information for CALCIUM
Drug Sales Revenues:	Drug sales revenues for CALCIUM
DailyMed Link:	CALCIUM at DailyMed

Drug patent expirations by year for CALCIUM

Drug Prices for CALCIUM

US Patents and Regulatory Information for CALCIUM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal	CALCIUM GLUCONATE IN SODIUM CHLORIDE	calcium gluconate	SOLUTION;INTRAVENOUS	217174-001	Sep 5, 2023		RX	No	Yes	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
B Braun Medical	CALCIUM GLUCONATE	calcium gluconate	SOLUTION;INTRAVENOUS	216541-001	Aug 21, 2023	AP	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Hq Spclt Pharma	CALCIUM GLUCONATE IN SODIUM CHLORIDE	calcium gluconate	SOLUTION;INTRAVENOUS	210906-002	Oct 29, 2018		RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free	Y			⤷ Get Started Free
Hq Spclt Pharma	CALCIUM GLUCONATE IN SODIUM CHLORIDE	calcium gluconate	SOLUTION;INTRAVENOUS	210906-001	Oct 29, 2018		RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free	Y			⤷ Get Started Free
Hq Spclt Pharma	CALCIUM GLUCONATE IN SODIUM CHLORIDE	calcium gluconate	SOLUTION;INTRAVENOUS	210906-002	Oct 29, 2018		RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free	Y			⤷ Get Started Free
Lilly	CALCIUM GLUCEPTATE	calcium gluceptate	INJECTABLE;INJECTION	006470-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Fresenius Kabi Usa	CALCIUM GLUCONATE	calcium gluconate	SOLUTION;INTRAVENOUS	208418-001	Jun 15, 2017	AP	RX	Yes	Yes	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.